Prestige Wealth Management Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $54.8K | Sell |
135
-1
| -0.7% | -$406 | 0.01% | 245 |
|
2025
Q1 | $67.7K | Hold |
136
| – | – | 0.01% | 227 |
|
2024
Q4 | $70.8K | Hold |
136
| – | – | 0.01% | 227 |
|
2024
Q3 | $84.2K | Buy |
136
+75
| +123% | +$46.4K | 0.02% | 205 |
|
2024
Q2 | $33.8K | Buy |
61
+6
| +11% | +$3.32K | 0.01% | 261 |
|
2024
Q1 | $32K | Hold |
55
| – | – | 0.01% | 292 |
|
2023
Q4 | $29.2K | Sell |
55
-18
| -25% | -$9.56K | 0.01% | 296 |
|
2023
Q3 | $37K | Buy |
73
+11
| +18% | +$5.57K | 0.01% | 266 |
|
2023
Q2 | $32.4K | Sell |
62
-1,124
| -95% | -$587K | 0.01% | 303 |
|
2023
Q1 | $684K | Buy |
1,186
+1,116
| +1,594% | +$644K | 0.17% | 64 |
|
2022
Q4 | $38.6K | Sell |
70
-976
| -93% | -$538K | 0.01% | 277 |
|
2022
Q3 | $531K | Buy |
1,046
+109
| +12% | +$55.3K | 0.15% | 67 |
|
2022
Q2 | $510K | Buy |
937
+6
| +0.6% | +$3.27K | 0.14% | 71 |
|
2022
Q1 | $550K | Buy |
931
+871
| +1,452% | +$515K | 0.14% | 74 |
|
2021
Q4 | $40K | Buy |
60
+7
| +13% | +$4.67K | 0.01% | 284 |
|
2021
Q3 | $30K | Buy |
53
+8
| +18% | +$4.53K | 0.01% | 312 |
|
2021
Q2 | $23K | Buy |
45
+2
| +5% | +$1.02K | 0.01% | 345 |
|
2021
Q1 | $20K | Sell |
43
-1
| -2% | -$465 | 0.01% | 364 |
|
2020
Q4 | $20K | Sell |
44
-111
| -72% | -$50.5K | 0.01% | 358 |
|
2020
Q3 | $69K | Hold |
155
| – | – | 0.02% | 207 |
|
2020
Q2 | $56K | Sell |
155
-219
| -59% | -$79.1K | 0.02% | 211 |
|
2020
Q1 | $106K | Buy |
374
+263
| +237% | +$74.5K | 0.04% | 121 |
|
2019
Q4 | $36K | Sell |
111
-7
| -6% | -$2.27K | 0.02% | 228 |
|
2019
Q3 | $34K | Buy |
118
+8
| +7% | +$2.31K | 0.02% | 226 |
|
2019
Q2 | $32K | Hold |
110
| – | – | 0.02% | 225 |
|
2019
Q1 | $30K | Sell |
110
-103
| -48% | -$28.1K | 0.02% | 226 |
|
2018
Q4 | $48K | Buy |
+213
| New | +$48K | 0.04% | 197 |
|